The genetics of uveal melanoma: An emerging framework for targeted therapy

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Uveal melanoma is the second most common form of melanoma and the most common primary intraocular malignancy. Until recently, very little was known about the genetics of this aggressive cancer. Mutations in oncogenes and tumor suppressors that are common in other cancers are conspicuously absent in uveal melanoma. In recent years, however, uveal melanoma has begun to yield its secrets, and a fascinating picture is emerging of how it develops and progresses. Mutations in the G q alpha subunits, encoded by GNAQ and GNA11, appear to be early or perhaps initiating events that require further mutations for malignant transformation. On the other hand, mutations in the BRCA1-associated protein-1 (BAP1) appear to occur later and demarcate a molecular brink beyond which metastasis becomes highly likely. BAP1 mutations can also occur in the germline, leading to a distinctive cancer predisposition syndrome. These mutations appear to be key events that provide the potential for targeted therapy. This article will review the genetic findings in uveal melanoma over the past two decades and suggest important areas for future work.

Original languageEnglish
Pages (from-to)171-181
Number of pages11
JournalPigment Cell and Melanoma Research
Volume25
Issue number2
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

Fingerprint

Mutation
BRCA1 Protein
Tumors
Proteins
Neoplasms
Therapeutics
Oncogenes
Uveal melanoma
Genetics
Melanoma
Neoplasm Metastasis

Keywords

  • BAP1
  • Eye
  • GNA11
  • GNAQ
  • Melanoma
  • Metastasis

ASJC Scopus subject areas

  • Dermatology
  • Oncology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The genetics of uveal melanoma : An emerging framework for targeted therapy. / William Harbour, J.

In: Pigment Cell and Melanoma Research, Vol. 25, No. 2, 01.03.2012, p. 171-181.

Research output: Contribution to journalArticle

@article{99f41a270a454ccb97de37c80e010d65,
title = "The genetics of uveal melanoma: An emerging framework for targeted therapy",
abstract = "Uveal melanoma is the second most common form of melanoma and the most common primary intraocular malignancy. Until recently, very little was known about the genetics of this aggressive cancer. Mutations in oncogenes and tumor suppressors that are common in other cancers are conspicuously absent in uveal melanoma. In recent years, however, uveal melanoma has begun to yield its secrets, and a fascinating picture is emerging of how it develops and progresses. Mutations in the G q alpha subunits, encoded by GNAQ and GNA11, appear to be early or perhaps initiating events that require further mutations for malignant transformation. On the other hand, mutations in the BRCA1-associated protein-1 (BAP1) appear to occur later and demarcate a molecular brink beyond which metastasis becomes highly likely. BAP1 mutations can also occur in the germline, leading to a distinctive cancer predisposition syndrome. These mutations appear to be key events that provide the potential for targeted therapy. This article will review the genetic findings in uveal melanoma over the past two decades and suggest important areas for future work.",
keywords = "BAP1, Eye, GNA11, GNAQ, Melanoma, Metastasis",
author = "{William Harbour}, J.",
year = "2012",
month = "3",
day = "1",
doi = "10.1111/j.1755-148X.2012.00979.x",
language = "English",
volume = "25",
pages = "171--181",
journal = "Pigment Cell and Melanoma Research",
issn = "1755-1471",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The genetics of uveal melanoma

T2 - An emerging framework for targeted therapy

AU - William Harbour, J.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Uveal melanoma is the second most common form of melanoma and the most common primary intraocular malignancy. Until recently, very little was known about the genetics of this aggressive cancer. Mutations in oncogenes and tumor suppressors that are common in other cancers are conspicuously absent in uveal melanoma. In recent years, however, uveal melanoma has begun to yield its secrets, and a fascinating picture is emerging of how it develops and progresses. Mutations in the G q alpha subunits, encoded by GNAQ and GNA11, appear to be early or perhaps initiating events that require further mutations for malignant transformation. On the other hand, mutations in the BRCA1-associated protein-1 (BAP1) appear to occur later and demarcate a molecular brink beyond which metastasis becomes highly likely. BAP1 mutations can also occur in the germline, leading to a distinctive cancer predisposition syndrome. These mutations appear to be key events that provide the potential for targeted therapy. This article will review the genetic findings in uveal melanoma over the past two decades and suggest important areas for future work.

AB - Uveal melanoma is the second most common form of melanoma and the most common primary intraocular malignancy. Until recently, very little was known about the genetics of this aggressive cancer. Mutations in oncogenes and tumor suppressors that are common in other cancers are conspicuously absent in uveal melanoma. In recent years, however, uveal melanoma has begun to yield its secrets, and a fascinating picture is emerging of how it develops and progresses. Mutations in the G q alpha subunits, encoded by GNAQ and GNA11, appear to be early or perhaps initiating events that require further mutations for malignant transformation. On the other hand, mutations in the BRCA1-associated protein-1 (BAP1) appear to occur later and demarcate a molecular brink beyond which metastasis becomes highly likely. BAP1 mutations can also occur in the germline, leading to a distinctive cancer predisposition syndrome. These mutations appear to be key events that provide the potential for targeted therapy. This article will review the genetic findings in uveal melanoma over the past two decades and suggest important areas for future work.

KW - BAP1

KW - Eye

KW - GNA11

KW - GNAQ

KW - Melanoma

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=84857443037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857443037&partnerID=8YFLogxK

U2 - 10.1111/j.1755-148X.2012.00979.x

DO - 10.1111/j.1755-148X.2012.00979.x

M3 - Article

C2 - 22268848

AN - SCOPUS:84857443037

VL - 25

SP - 171

EP - 181

JO - Pigment Cell and Melanoma Research

JF - Pigment Cell and Melanoma Research

SN - 1755-1471

IS - 2

ER -